^SAMPLE = GSM503023!Sample_title = LoVo-92/4OHP oxaliplatin resistant!Sample_geo_accession = GSM503023!Sample_status = Public on Mar 01 2014!Sample_submission_date = Feb 01 2010!Sample_last_update_date = Mar 01 2014!Sample_type = genomic!Sample_channel_count = 2!Sample_source_name_ch1 = LoVo-92/4OHP!Sample_organism_ch1 = Homo sapiens!Sample_taxid_ch1 = 9606!Sample_characteristics_ch1 = cell line: LoVo-92/4OHP!Sample_treatment_protocol_ch1 = Induced resistance to oxaliplatin with increasing concentrations. Weekly exposure of 4hrs!Sample_growth_protocol_ch1 = LoVo-92/4OHP cells were maintained in RPMI supplemented with 10% FCS!Sample_molecule_ch1 = genomic DNA!Sample_extract_protocol_ch1 = DNA was isolated using the Wizard Genomic DNA Purification kit (Promega Benelux, Leiden, The Netherlands) according the manufacturerâs protocol.!Sample_label_ch1 = Cy3!Sample_label_protocol_ch1 = DNA labeling protocol according to Enzo Life Sciences!Sample_source_name_ch2 = LoVo-92!Sample_organism_ch2 = Homo sapiens!Sample_taxid_ch2 = 9606!Sample_characteristics_ch2 = cell line: LoVo-92 (parental)!Sample_growth_protocol_ch2 = LoVo-92 cells were maintained in RPMI supplemented with 10% FCS!Sample_molecule_ch2 = genomic DNA!Sample_extract_protocol_ch2 = DNA was isolated using the Wizard Genomic DNA Purification kit (Promega Benelux, Leiden, The Netherlands) according the manufacturerâs protocol.!Sample_label_ch2 = Cy3!Sample_label_protocol_ch2 = DNA labeling protocol according to Enzo Life Sciences!Sample_hyb_protocol = Hybridization protocol available via www.agilent.com!Sample_scan_protocol = Slides were scanned using the Agilent microarray scanner, protocol according to Agilent.!Sample_description = protocols according to manufacturer (Enzo Life Sciences www.agilent.com)!Sample_data_processing = Images were auto gridded, analyzed and data extracted using Agilent Feature Extraction software (version 9.5.1.1). Raw expression data generated by the Feature Extraction software was normalised and smoothend using the R-script "NOWAVE" as described in: Smoothing waves in array CGH tumor profiles, Bioinformatics. 2009 May 1;25(9):1099-104.!Sample_platform_id = GPL5477!Sample_contact_name = Daoud,,Sie!Sample_contact_email = d.sie@vumc.nl!Sample_contact_phone = +31 20 4442428!Sample_contact_laboratory = Microarray Core Facility!Sample_contact_department = Pathology!Sample_contact_institute = Vrije Universiteit Medical Center!Sample_contact_address = De Boelelaan 1117!Sample_contact_city = Amsterdam!Sample_contact_zip/postal_code = 1081 HV!Sample_contact_country = Netherlands!Sample_supplementary_file = NONE!Sample_series_id = GSE20144!Sample_data_row_count = 45214#ID_REF = #VALUE = norm log2 ratio (resistant/parental)#MAL_251495014120_S01_CGH-v4_95_Feb07_1_1_gBGSubSignal = LoVo-92/4OHP#MAL_251495014120_S01_CGH-v4_95_Feb07_1_2_gBGSubSignal = LoVo-92!sample_table_beginID_REF	VALUE	MAL_251495014120_S01_CGH-v4_95_Feb07_1_1_gBGSubSignal	MAL_251495014120_S01_CGH-v4_95_Feb07_1_2_gBGSubSignal1		6156.06	3433.42	-0.259338	-12.1234	-6.67823	-0.018238	-12.7977	-9.413664	0.282662	-12.635	-8.29145	-0.302338	-13.0687	-7.483236	-0.343338	-11.3644	-6.746317	-0.004508	-13.1904	-8.192298	-0.410338	-12.7111	-6.764699	-0.126338	-14.4048	-5.9073310	-0.104338	-11.0319	-5.6218911	-0.199338	-14.1316	-8.1355312	-0.231338	1073.28	888.67513		1190.1	1162.1114	-0.332338	6573.31	5196.0515	0.067462	672.265	598.20716	-0.127338	1139.35	1050.3817	-0.165338	2958.69	2650.0918	0.053862	680.558	499.14619	0.186662	397.755	362.13620	0.004192	620.962	466.679!sample_table_end